A 61-year-old woman with heterozygous familial hypercholesterolemia and lifelong LDL levels >200 mg/dL had a complete absence of atherosclerosis on imaging.
Case Report (n=1)
Patients with heterozygous familial hypercholesterolemia can have an absence of atherosclerosis despite lifelong severely elevated LDL levels.
BACKGROUND: Familial hypercholesterolemia (FH) is a genetic condition characterized by high levels of low-density lipoprotein (LDL) and early atherosclerotic cardiovascular disease. CASE SUMMARY: Our patient was a 61-year-old woman who had been referred to a cardiologist for LDL levels >200 mg/dL for more than a decade. She tested positive for a pathogenic LDLR mutation and was diagnosed with FH. She then underwent risk stratification with coronary computed tomography angiography and ultrasound of the carotid arteries, both of which showed no atherosclerotic disease. She continues to do well off statins. DISCUSSION: Coronary artery calcifications can be seen as early as 11 to 23 years of age in patients with FH. Our patient did not have any evidence of atherosclerotic disease, nor did she have a family history of cardiovascular disease, and it was thought that she may have a protective factor affecting LDL metabolism. TAKE-HOME MESSAGE: Patients with heterozygous FH can have absence of atherosclerosis despite lifelong severely elevated LDL levels.
Arora et al. (Fri,) conducted a case report in Familial hypercholesterolemia (n=1). Heterozygous familial hypercholesterolemia with severely elevated LDL levels was evaluated on Atherosclerotic disease. A 61-year-old woman with heterozygous familial hypercholesterolemia and lifelong LDL levels >200 mg/dL had a complete absence of atherosclerosis on imaging.